Global Paclitaxel Injection Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Report ID: GIR2112280222 | Category: Pharma & Healthcare | Pages: 103 | Format: PDF | Published Date: November 14,2022

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

The Paclitaxel Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Paclitaxel Injection market size is estimated to be worth US$ 3482 million in 2021 and is forecast to a readjusted size of USD 7058.9 million by 2028 with a CAGR of 10.6% during review period. Ovarian Cancer accounting for % of the Paclitaxel Injection global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 5ml,30mg segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Paclitaxel Injection include Bristol-Myers Squibb, Celgene Corporation, Hospira, Biological E., and Taj Accura, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Paclitaxel Injection market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
    5ml,30mg
    10ml,60mg
    16.7ml,100mg
    25ml,150mg
    50ml,300mg
Market segment by Application can be divided into
    Ovarian Cancer
    Breast Cancer
    Cervical Cancer
    Pancreatic Cancer
    Other
The key market players for global Paclitaxel Injection market are listed below:
    Bristol-Myers Squibb
    Celgene Corporation
    Hospira
    Biological E.
    Taj Accura
    Khandelwal Laboratories
    Luye Pharma
    Beijing Youcare
    Beijing Union
    Haiyao
    Chuntch
Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Paclitaxel Injection product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Paclitaxel Injection, with price, sales, revenue and global market share of Paclitaxel Injection from 2019 to 2022.
Chapter 3, the Paclitaxel Injection competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Paclitaxel Injection breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Paclitaxel Injection market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Paclitaxel Injection.
Chapter 13, 14, and 15, to describe Paclitaxel Injection sales channel, distributors, customers, research findings and conclusion, appendix and data source.

1 Market Overview
    1.1 Paclitaxel Injection Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Paclitaxel Injection Revenue by Type: 2017 Versus 2021 Versus 2028
        1.2.2 5ml,30mg
        1.2.3 10ml,60mg
        1.2.4 16.7ml,100mg
        1.2.5 25ml,150mg
        1.2.6 50ml,300mg
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Paclitaxel Injection Revenue by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Ovarian Cancer
        1.3.3 Breast Cancer
        1.3.4 Cervical Cancer
        1.3.5 Pancreatic Cancer
        1.3.6 Other
    1.4 Global Paclitaxel Injection Market Size & Forecast
        1.4.1 Global Paclitaxel Injection Sales in Value (2017 & 2021 & 2028)
        1.4.2 Global Paclitaxel Injection Sales in Volume (2017-2028)
        1.4.3 Global Paclitaxel Injection Price (2017-2028) 
    1.5 Global Paclitaxel Injection Production Capacity Analysis
        1.5.1 Global Paclitaxel Injection Total Production Capacity (2017-2028)
        1.5.2 Global Paclitaxel Injection Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Paclitaxel Injection Market Drivers
        1.6.2 Paclitaxel Injection Market Restraints
        1.6.3 Paclitaxel Injection Trends Analysis
2 Manufacturers Profiles
    2.1 Bristol-Myers Squibb
        2.1.1 Bristol-Myers Squibb Details
        2.1.2 Bristol-Myers Squibb Major Business
        2.1.3 Bristol-Myers Squibb Paclitaxel Injection Product and Services
        2.1.4 Bristol-Myers Squibb Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.2 Celgene Corporation
        2.2.1 Celgene Corporation Details
        2.2.2 Celgene Corporation Major Business
        2.2.3 Celgene Corporation Paclitaxel Injection Product and Services
        2.2.4 Celgene Corporation Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.3 Hospira
        2.3.1 Hospira Details
        2.3.2 Hospira Major Business
        2.3.3 Hospira Paclitaxel Injection Product and Services
        2.3.4 Hospira Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.4 Biological E.
        2.4.1 Biological E. Details
        2.4.2 Biological E. Major Business
        2.4.3 Biological E. Paclitaxel Injection Product and Services
        2.4.4 Biological E. Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.5 Taj Accura
        2.5.1 Taj Accura Details
        2.5.2 Taj Accura Major Business
        2.5.3 Taj Accura Paclitaxel Injection Product and Services
        2.5.4 Taj Accura Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.6 Khandelwal Laboratories
        2.6.1 Khandelwal Laboratories Details
        2.6.2 Khandelwal Laboratories Major Business
        2.6.3 Khandelwal Laboratories Paclitaxel Injection Product and Services
        2.6.4 Khandelwal Laboratories Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.7 Luye Pharma
        2.7.1 Luye Pharma Details
        2.7.2 Luye Pharma Major Business
        2.7.3 Luye Pharma Paclitaxel Injection Product and Services
        2.7.4 Luye Pharma Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.8 Beijing Youcare
        2.8.1 Beijing Youcare Details
        2.8.2 Beijing Youcare Major Business
        2.8.3 Beijing Youcare Paclitaxel Injection Product and Services
        2.8.4 Beijing Youcare Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.9 Beijing Union
        2.9.1 Beijing Union Details
        2.9.2 Beijing Union Major Business
        2.9.3 Beijing Union Paclitaxel Injection Product and Services
        2.9.4 Beijing Union Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.10 Haiyao
        2.10.1 Haiyao Details
        2.10.2 Haiyao Major Business
        2.10.3 Haiyao Paclitaxel Injection Product and Services
        2.10.4 Haiyao Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.11 Chuntch
        2.11.1 Chuntch Details
        2.11.2 Chuntch Major Business
        2.11.3 Chuntch Paclitaxel Injection Product and Services
        2.11.4 Chuntch Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Paclitaxel Injection Breakdown Data by Manufacturer
    3.1 Global Paclitaxel Injection Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
    3.2 Global Paclitaxel Injection Revenue by Manufacturer (2019, 2020, 2021, and 2022)
    3.3 Key Manufacturer Market Position in Paclitaxel Injection
    3.4 Market Concentration Rate
        3.4.1 Top 3 Paclitaxel Injection Manufacturer Market Share in 2021
        3.4.2 Top 6 Paclitaxel Injection Manufacturer Market Share in 2021
    3.5 Global Paclitaxel Injection Production Capacity by Company: 2021 VS 2022
    3.6 Manufacturer by Geography: Head Office and Paclitaxel Injection Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions
4 Market Analysis by Region
    4.1 Global Paclitaxel Injection Market Size by Region
        4.1.1 Global Paclitaxel Injection Sales in Volume by Region (2017-2028)
        4.1.2 Global Paclitaxel Injection Revenue by Region (2017-2028)
    4.2 North America Paclitaxel Injection Revenue (2017-2028)
    4.3 Europe Paclitaxel Injection Revenue (2017-2028)
    4.4 Asia-Pacific Paclitaxel Injection Revenue (2017-2028)
    4.5 South America Paclitaxel Injection Revenue (2017-2028)
    4.6 Middle East and Africa Paclitaxel Injection Revenue (2017-2028)
5 Market Segment by Type
    5.1 Global Paclitaxel Injection Sales in Volume by Type (2017-2028)
    5.2 Global Paclitaxel Injection Revenue by Type (2017-2028)
    5.3 Global Paclitaxel Injection Price by Type (2017-2028)
6 Market Segment by Application
    6.1 Global Paclitaxel Injection Sales in Volume by Application (2017-2028)
    6.2 Global Paclitaxel Injection Revenue by Application (2017-2028)
    6.3 Global Paclitaxel Injection Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
    7.1 North America Paclitaxel Injection Sales by Type (2017-2028)
    7.2 North America Paclitaxel Injection Sales by Application (2017-2028)
    7.3 North America Paclitaxel Injection Market Size by Country
        7.3.1 North America Paclitaxel Injection Sales in Volume by Country (2017-2028)
        7.3.2 North America Paclitaxel Injection Revenue by Country (2017-2028)
        7.3.3 United States Market Size and Forecast (2017-2028)
        7.3.4 Canada Market Size and Forecast (2017-2028)
        7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
    8.1 Europe Paclitaxel Injection Sales by Type (2017-2028)
    8.2 Europe Paclitaxel Injection Sales by Application (2017-2028)
    8.3 Europe Paclitaxel Injection Market Size by Country
        8.3.1 Europe Paclitaxel Injection Sales in Volume by Country (2017-2028)
        8.3.2 Europe Paclitaxel Injection Revenue by Country (2017-2028)
        8.3.3 Germany Market Size and Forecast (2017-2028)
        8.3.4 France Market Size and Forecast (2017-2028)
        8.3.5 United Kingdom Market Size and Forecast (2017-2028)
        8.3.6 Russia Market Size and Forecast (2017-2028)
        8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
    9.1 Asia-Pacific Paclitaxel Injection Sales by Type (2017-2028)
    9.2 Asia-Pacific Paclitaxel Injection Sales by Application (2017-2028)
    9.3 Asia-Pacific Paclitaxel Injection Market Size by Region
        9.3.1 Asia-Pacific Paclitaxel Injection Sales in Volume by Region (2017-2028)
        9.3.2 Asia-Pacific Paclitaxel Injection Revenue by Region (2017-2028)
        9.3.3 China Market Size and Forecast (2017-2028)
        9.3.4 Japan Market Size and Forecast (2017-2028)
        9.3.5 Korea Market Size and Forecast (2017-2028)
        9.3.6 India Market Size and Forecast (2017-2028)
        9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
        9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
    10.1 South America Paclitaxel Injection Sales by Type (2017-2028)
    10.2 South America Paclitaxel Injection Sales by Application (2017-2028)
    10.3 South America Paclitaxel Injection Market Size by Country
        10.3.1 South America Paclitaxel Injection Sales in Volume by Country (2017-2028)
        10.3.2 South America Paclitaxel Injection Revenue by Country (2017-2028)
        10.3.3 Brazil Market Size and Forecast (2017-2028)
        10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Paclitaxel Injection Sales by Type (2017-2028)
    11.2 Middle East & Africa Paclitaxel Injection Sales by Application (2017-2028)
    11.3 Middle East & Africa Paclitaxel Injection Market Size by Country
        11.3.1 Middle East & Africa Paclitaxel Injection Sales in Volume by Country (2017-2028)
        11.3.2 Middle East & Africa Paclitaxel Injection Revenue by Country (2017-2028)
        11.3.3 Turkey Market Size and Forecast (2017-2028)
        11.3.4 Egypt Market Size and Forecast (2017-2028)
        11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
        11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
    12.1 Raw Material of Paclitaxel Injection and Key Manufacturers
    12.2 Manufacturing Costs Percentage of Paclitaxel Injection
    12.3 Paclitaxel Injection Production Process
    12.4 Paclitaxel Injection Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
    13.2 Paclitaxel Injection Typical Distributors
    13.3 Paclitaxel Injection Typical Customers
14 Research Findings and Conclusion
15 Appendix
    15.1 Methodology
    15.2 Research Process and Data Source
    15.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Paclitaxel Injection Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?